CD34 and classic Hodgkin lymphoma: Several studies have shown that CD34+ cells can affect disease progression, as a high dose of CD34+ cells is associated with better outcome in cHL [7], and the use of CD34+ cells for autografting is feasible, safe, and an effective procedure for relapsed and refractory HL [8].